. 2012 Sep;14(9):799–803. doi: 10.1089/dia.2012.0027

Table 3.

Values of Cellular Parameters Investigated Before and After Therapy

	Mean±SD for investigated parameter
Timing, group	Nuclear area (μm)	Perimeter	Nuclear circularity	Ferret's diameter (μm)	Integral optical density (au)
Before therapy
1 (DM type 1)	107.28±15.42	39.11±2.77	0.87±0.03	13.56±1.08	28.51±5.82
2 (DM type 2)	103.50±14.52	38.42±2.60	0.87±0.03	13.57±0.96	24.62±4.71
3 (control)	77.29±7.87^ab	33.40±1.80^ab	0.86±0.03^ab	11.98±0.87^ab	18.20±3.55^ab
After therapy
Lasered side
1 (DM type 1)	40.69±4.91^*	24.87±1.93^*	0.82±0.05^*	9.01±1.05^*	14.23±3.03^*
2 (DM type 2)	39.91±3.39^*	24.63±1.32^*	0.82±0.07^*	8.82±0.74^*	14.21±2.48^*
3 (control)	39.40±3.71^*	24.30±1.56^*	0.84±0.06^*	8.72±0.84^*	10.62±1.95^*
Non-lasered side
1 (DM type 1)	52.03±4.97^*^†	27.79±1.02^*^†	0.84±0.03^*^†	10.25±0.67^*^†	16.41±3.16^*^†
2 (DM type 2)	54.30±5.07^*^†	28.03±1.43^*^†	0.86±0.03^*^†	9.90±0.87^*^†	17.52±4.93^*^†
3 (control)	51.09±5.99^*^†cd	27.64±1.70^*^†cd	0.83±0.06^*^†cd	10.09±0.82^*^†cd	16.74±2.84^*^†cd

Significant (P<0.01) differences are indicated: before therapy, ^aGroup 2 versus Group 3, ^bGroup 1 versus Group 3; after therapy, ^cGroup 2 versus Group 3, ^dGroup 1 versus Group 3; ^*after therapy versus before therapy; ^†after therapy lasered versus non-lasered side.

au, absorbance units; DM, diabetes mellitus.